Salt Lake City, UT (October 26, 2023) 4Life Research and Development scientists published their findings in a peer-reviewed scientific journal: Current Therapeutic Research. The studies measured the immunomodulatory effects of 4Life Transfer Factor
® and 4Life Transfer Factor products.
Vice President of Product Development Lawry Han, PhD, FACN; Chief Scientific Officer David Vollmer, PhD; and Health Sciences Advisory Board member Elena Y. Enioutina, MD, PhD coauthored the newly published research article: “Immunomodulatory Effects of Modified Bovine Colostrum, Whey, and Their Combination with Other Natural Products: Effects on Human Peripheral Blood Mononuclear Cells.”
Vollmer: “That’s a really long title for findings that are simple, yet important: 4Life Transfer Factor can do more than just boost immune function. While we’ve demonstrated 4Life Transfer Factor’s immune-activating benefits across many different studies, our latest data reveals that 4Life Transfer Factor can also calm overactive immune function’s. This new, independent research has wide-ranging applications across many aspects of wellness, particularly for those who can benefit from balancing immune health.”
The researchers studied a variety of 4Life proprietary products and formulas: 4Life
® Transfer Factor Plus
® Tri-Factor
® Formula, UltraFactor
® in 4Life Transfer Factor
® Classic, NanoFactor
®, OvoFactor
®, Tri-Factor
® Formula in 4Life Transfer Factor Plus Tri-Factor Formula, the supermushroom blend in the botanical blend of 4Life Transfer Factor Plus Tri-Factor Formula, and the whey protein concentrate in NutraStart
® Blue Vanilla.
All ingredients studied showed positive effects in modulating innate and adaptive immune function activity.
4Life, Do Life Differently
®, and the first to bring transfer factor research to market, has offices in dozens of countries to serve the company’s worldwide customers.
For more information:
Calvin Jolley
Vice President Corporate Communications
4Life Research
[email protected]
